Despite great advances in the treatment of liver hepatocellular carcinoma (LIHC), such as
immunotherapy, the prognosis remains extremely poor, and there is an urgent need to …

Background: Hepatocellular carcinoma (HCC) remains the most prevalent gastrointestinal
malignancy worldwide, with robust drug resistance to therapy. N7-methylguanosine (m7G) …

Hepatocellular carcinoma (HCC) is a highly invasive malignancy prone to recurrence, and
patients with HCC have a low 5-year survival rate. Long non-coding RNAs (lncRNAs) play a …

Background: RNA methylation modifications are important post-translational modifications
that are regulated in an epigenetic manner. Recently, N 6-methyladenosine (m 6 A) RNA …

5-Methyladenosine (m5C) is a type of epigenetic modification involved in the progression of
various cancers. To investigate the role of m5C-related long non-coding RNAs (lncRNAs) in …

Background N7-methylguanosine (m7G) is one of the most common RNA posttranscriptional
modifications; however, its potential role in hepatocellular carcinoma (HCC) remains …

Simple Summary The relationship between m1A-related lncRNAs and HCC is still unclear.
In this study, five m1A-related lncRNAs (AL031985. 3, NRAV, WAC-AS1, AC026412. 3, and …

N6-methyladenosine (m6a)-related mRNAs and lncRNAs have been explored for their
functions in several cancers. The present study aimed to identify potential signatures of m6a …

Abstract N6-methyladenosine (m6A) methyltransferase has been shown to be an oncogene
in a variety of cancers. Nevertheless, the relationship between the long non-coding RNAs …

Background Liver hepatocellular carcinoma (LIHC) is a lethal cancer. This study aimed to
identify the N6‐methyladenosine (m6A)‐targeted long non‐coding RNA (lncRNA) related to …